223 related articles for article (PubMed ID: 17949576)
21. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
22. Gynecologic problems of menopausal women: part 2. Treating estrogen deficiency.
Notelovitz M
Geriatrics; 1978 Sep; 33(9):35-7, 41-2. PubMed ID: 680564
[No Abstract] [Full Text] [Related]
23. Estrogens for the menopause. Maximizing benefits, minimizing risks.
Seller JC
Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
[TBL] [Abstract][Full Text] [Related]
24. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
25. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
26. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
27. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
29. Menopause and estrogen replacement therapy.
Stuenkel CA
Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
31. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
Stefanick ML
Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
[TBL] [Abstract][Full Text] [Related]
32. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
33. Low dose hormone replacement therapy: clinical efficacy.
Mattsson LA; Sporrong T
Minerva Ginecol; 2003 Jun; 55(3):201-7. PubMed ID: 14581865
[TBL] [Abstract][Full Text] [Related]
34. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
Ayres de Campos D; Barros H; Martinez de Oliveira J
Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
[TBL] [Abstract][Full Text] [Related]
35. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
Gastel B; Cornoni-Huntley J; Brody JA
J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
[TBL] [Abstract][Full Text] [Related]
36. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
38. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
39. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
40. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
